呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

奥马珠单抗治疗过敏性哮喘的中国专家共识

2018-03-10 中华医学会呼吸病学分会哮喘学组 中华结核和呼吸杂志, 2018,41(3) :179-185.

奥马珠单抗过敏性哮喘

为了规范奥马珠单抗治疗过敏性哮喘的临床应用，建立适用于中国患者的优化治疗方案，奥马珠单抗治疗过敏性哮喘专家组和中华医学会呼吸病学分会哮喘学组组织数十位专家结合国内外循证医学证据，对奥马珠单抗治疗过敏性哮喘的相关问题进行了充分的讨论，达成了奥马珠单抗治疗过敏性哮喘的专家共识，以供临床医生在使用奥马珠单抗治疗过敏性哮喘时参考。

中文标题：

奥马珠单抗治疗过敏性哮喘的中国专家共识

发布机构：

中华医学会呼吸病学分会哮喘学组

发布日期：

2018-03-10

简要介绍：

为了规范奥马珠单抗治疗过敏性哮喘的临床应用，建立适用于中国患者的优化治疗方案，奥马珠单抗治疗过敏性哮喘专家组和中华医学会呼吸病学分会哮喘学组组织数十位专家结合国内外循证医学证据，对奥马珠单抗治疗过敏性哮喘的相关问题进行了充分的讨论，达成了奥马珠单抗治疗过敏性哮喘的专家共识，以供临床医生在使用奥马珠单抗治疗过敏性哮喘时参考。

 

拓展指南：与哮喘相关指南：

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=949831, encodeId=cd1594983183, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:47 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902264, encodeId=fdbe90226496, content=学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bada4796040, createdName=yinzhangyong, createdTime=Wed Nov 25 20:27:39 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296976, encodeId=9e802969e617, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Mar 17 06:16:34 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296843, encodeId=1d7a296843d2, content=感谢分享.学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Fri Mar 16 17:55:20 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296647, encodeId=f06829664e35, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Mar 16 06:29:52 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2021-03-20 ms5000001146316601

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=949831, encodeId=cd1594983183, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:47 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902264, encodeId=fdbe90226496, content=学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bada4796040, createdName=yinzhangyong, createdTime=Wed Nov 25 20:27:39 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296976, encodeId=9e802969e617, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Mar 17 06:16:34 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296843, encodeId=1d7a296843d2, content=感谢分享.学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Fri Mar 16 17:55:20 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296647, encodeId=f06829664e35, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Mar 16 06:29:52 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2020-11-25 yinzhangyong

    学习了，感谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=949831, encodeId=cd1594983183, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:47 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902264, encodeId=fdbe90226496, content=学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bada4796040, createdName=yinzhangyong, createdTime=Wed Nov 25 20:27:39 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296976, encodeId=9e802969e617, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Mar 17 06:16:34 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296843, encodeId=1d7a296843d2, content=感谢分享.学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Fri Mar 16 17:55:20 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296647, encodeId=f06829664e35, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Mar 16 06:29:52 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-17 1e1c07bdm01(暂无匿称)

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=949831, encodeId=cd1594983183, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:47 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902264, encodeId=fdbe90226496, content=学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bada4796040, createdName=yinzhangyong, createdTime=Wed Nov 25 20:27:39 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296976, encodeId=9e802969e617, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Mar 17 06:16:34 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296843, encodeId=1d7a296843d2, content=感谢分享.学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Fri Mar 16 17:55:20 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296647, encodeId=f06829664e35, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Mar 16 06:29:52 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-16 ms2296823935859672

    感谢分享.学习了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=949831, encodeId=cd1594983183, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:46:47 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902264, encodeId=fdbe90226496, content=学习了，感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bada4796040, createdName=yinzhangyong, createdTime=Wed Nov 25 20:27:39 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296976, encodeId=9e802969e617, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Mar 17 06:16:34 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296843, encodeId=1d7a296843d2, content=感谢分享.学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/13/c36860368f59b7f042bac242c6785040.jpg, createdBy=457b1858657, createdName=ms2296823935859672, createdTime=Fri Mar 16 17:55:20 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296647, encodeId=f06829664e35, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Mar 16 06:29:52 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-16 txqjm

    谢谢了.学习

    0

以上为热门评论，梅斯医学App还有更多内容